At Cellebration, we have mastered the technology for isolating a maximum number of viable stem cells from either autologous (own) cells or allogeneic (donor) cells to treat patients with Vasculitis. We isolate and enrich the viable cell stems which will be infused into the patient.
These cells are administered through one of several methods after a considerable analysis of the patient’s unique history.
Local Administration
In this delivery mode, cells are infused into the peripheral veins to expand blood volumes in the system, to ensure that the maximum number of cells are reaching the targeted area.
Subcutaneous Administration
In this mode, cells are administered in the fat layer of the skin and can help regenerate skin cells, promoting restructuring of skin tissue layers.
Intravenous Administration
In this delivery mode, cells are infused into the peripheral veins to expand blood volumes in the system, to ensure that the maximum number of cells are reaching the targeted area.
Infused into the body, these cells can repopulate the damaged parts of the organ. Through paracrine effects, they differentiate into the damaged cells to restore function and continue to regulate the immune system and promote hormonal balance. These cells can regulate the immune system and reduce the impact of autoimmune disorders.
One of the important properties of mesenchymal stem cells is to promote proper vessel function which can improve the strength of blood vessels and promote synthesis of new vessels. Thus, with our highly specialized approach, it is now possible to obtain noticeable improvements in patients with Vasculitis, within the symptoms as well as improving functional abilities.